The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization

被引:124
作者
Chacko, BM
Qin, B
Correia, JJ
Lam, SS
de Caestecker, MP
Lin, K
机构
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA
[2] Vanderbilt Univ, Med Ctr, Dept Nephrol, Nashville, TN 37232 USA
[3] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA
关键词
D O I
10.1038/84995
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Smad proteins mediate the transforming growth factor beta responses. C-terminal phosphorylation of R-Smads leads to the recruitment of Smad4 and the formation of active signaling complexes. We investigated the mechanism of phosphorylation-induced Smad complex formation with an activating pseudo-phosphorylates Smad3. Pseudo-phosphorylated Smad3 has a greater propensity to homotrimerize, and recruits Smad4 to form a heterotrimer containing two Smad3 and one Smad4. The trimeric interaction is mediated through conserved interfaces to which tumorigenic mutations map. Furthermore, a conserved Arg residue within the L3 loop, located near the C-terminal phosphorylation sites of the neighboring subunit, is essential for trimerization. We propose that the phosphorylated C-terminal residues interact with the L3 loop of the neighboring subunit to stabilize the trimer interaction.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 33 条
[1]   T beta RI phosphorylation of Smad2 on Ser(465) and Ser(467) is required for Smad2-Smad4 complex formation and signaling [J].
Abdollah, S ;
MaciasSilva, M ;
Tsukazaki, T ;
Hayashi, H ;
Attisano, L ;
Wrana, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27678-27685
[2]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[3]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[4]  
CORREIA JJ, 2001, IN PRESS BIOCHEMISTR
[5]   Role of transforming growth factor-β signaling in cancer [J].
de Caestecker, MP ;
Piek, E ;
Roberts, AB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) :1388-1402
[6]   The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain [J].
de Caestecker, MP ;
Yahata, T ;
Wang, D ;
Parks, WT ;
Huang, SX ;
Hill, CS ;
Shioda, T ;
Roberts, AB ;
Lechleider, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :2115-2122
[7]   Characterization of functional domains within Smad4/DPC4 [J].
deCaestecker, MP ;
Hemmati, P ;
LarischBloch, S ;
Ajmera, R ;
Roberts, AB ;
Lechleider, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13690-13696
[8]   MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552
[9]   Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β [J].
Feng, XH ;
Lin, X ;
Derynck, R .
EMBO JOURNAL, 2000, 19 (19) :5178-5193
[10]   TGF-beta signalling from cell membrane to nucleus through SMAD proteins [J].
Heldin, CH ;
Miyazono, K ;
tenDijke, P .
NATURE, 1997, 390 (6659) :465-471